Informations techniques
Exploitant
Winthrop médicaments (Groupe Sanofi Aventis)
Présentation
DILRENE LP 300 mg, gélule à libération prolongée
B/ 28 - (Code CIP : 331 991-4)
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
45D1q8YD9wb7ckju